{"denoms":[{"counts":[{"groupId":"BG000","value":"70"},{"groupId":"BG001","value":"75"},{"groupId":"BG002","value":"145"}],"units":"Participants"}],"groups":[{"description":"Patients receive induction chemotherapy comprising docetaxel, cisplatin, and fluorouracil. Treatment repeats every 21 days for 3 courses. Patients achieving a pathologic complete response at the primary site and a clinical complete response in the neck then receive carboplatin once weekly and undergo concurrent radiotherapy once daily, 5 days a week, for 7 weeks. Patients with a partial response at the primary site (i.e., positive biopsy), stable disease, or radiographic evidence of persistent disease in the neck receive docetaxel once weekly for 4 weeks and undergo concurrent radiotherapy once or twice daily, 5 days a week, for 6 weeks.\n\ncisplatin : Given IV\n\nradiation therapy : Patients undergo radiation therapy once or twice daily, 5 days a week, for up to 7 weeks\n\ncarboplatin : Given IV\n\nfluorouracil : Given IV\n\ndocetaxel : Given IV","id":"BG000","title":"Arm I"},{"description":"Patients receive cisplatin IV on weeks 1 and 4 and undergo concurrent radiotherapy once or twice daily, 5 days a week, for 6 weeks.\n\ncisplatin : Given IV\n\nradiation therapy : Patients undergo radiation therapy once or twice daily, 5 days a week, for up to 7 weeks","id":"BG001","title":"Arm II"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"59"},{"groupId":"BG001","value":"66"},{"groupId":"BG002","value":"125"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"20"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9","value":"55"},{"groupId":"BG001","spread":"8","value":"54"},{"groupId":"BG002","spread":"8.4","value":"55"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"18"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"64"},{"groupId":"BG001","value":"63"},{"groupId":"BG002","value":"127"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"69"},{"groupId":"BG001","value":"69"},{"groupId":"BG002","value":"138"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"7"}]}],"title":"Germany"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}